Cargando…

Experimental Treatment of Ebola Virus Disease with Brincidofovir

BACKGROUND: The nucleotide analogue brincidofovir was developed to prevent and treat infections caused by double-stranded DNA viruses. Based on in vitro data suggesting an antiviral effect against Ebola virus, brincidofovir was included in the World Health Organisation list of agents that should be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dunning, Jake, Kennedy, Stephen B., Antierens, Annick, Whitehead, John, Ciglenecki, Iza, Carson, Gail, Kanapathipillai, Rupa, Castle, Lyndsey, Howell-Jones, Rebecca, Pardinaz-Solis, Raul, Grove, Jennifer, Scott, Janet, Lang, Trudie, Olliaro, Piero, Horby, Peter W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017617/ https://www.ncbi.nlm.nih.gov/pubmed/27611077 http://dx.doi.org/10.1371/journal.pone.0162199

Ejemplares similares

Regulatory and Operational Complexities of Conducting a Clinical Treatment Trial During an Ebola Virus Disease Epidemic
por: Rojek, Amanda M, et al.
Publicado: (2018)

Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial
por: Dunning, Jake, et al.
Publicado: (2016)

Evaluating Clinical Trial Designs for Investigational Treatments of Ebola Virus Disease
por: Cooper, Ben S., et al.
Publicado: (2015)

20.130 ISARIC – enhancing the clinical research response to epidemics
por: Pardinaz-Solis, R., et al.
Publicado: (2016)

Ethics of emerging infectious disease outbreak responses: Using Ebola virus disease as a case study of limited resource allocation
por: Nichol, Ariadne A., et al.
Publicado: (2021)

Cholera in Pregnancy: Outcomes from a Specialized Cholera Treatment Unit for Pregnant Women in Léogâne, Haiti
por: Ciglenecki, Iza, et al.
Publicado: (2013)

The Role of Brincidofovir in Preparation for a Potential Smallpox Outbreak
por: Foster, Scott A., et al.
Publicado: (2017)

Tecovirimat for Monkeypox in the Central African Republic under Expanded Access
por: Mbrenga, Festus, et al.
Publicado: (2022)

Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection
por: Chan, Shuk Ying, et al.
Publicado: (2021)

Monkeypox: how will we know if the treatments work?
por: Rojek, Amanda, et al.
Publicado: (2022)

Pharmacokinetics (PK) and Safety of Intravenous (IV) Brincidofovir (BCV) in Healthy Adult Subjects
por: Wire, Mary Beth, et al.
Publicado: (2017)

Brincidofovir (CMX001) for the Treatment of Severe Adenoviral Pneumonia in Kidney Transplant Recipient
por: Sudhindra, Praveen, et al.
Publicado: (2019)

Feasibility of Xpert Ebola Assay in Médecins Sans Frontières Ebola Program, Guinea
por: Van den Bergh, Rafael, et al.
Publicado: (2016)

Ebola Virus Disease Complications as Experienced by Survivors in Sierra Leone
por: Tiffany, Amanda, et al.
Publicado: (2016)

Successful Treatment of Adenovirus Infection with Brincidofovir in an Immunocompromised Patient after Hematological Stem Cell Transplantation
por: Van Genechten, T., et al.
Publicado: (2020)

Brincidofovir is a robust replication inhibitor against African swine fever virus in vivo and in vitro
por: Guo, Shibang, et al.
Publicado: (2023)

Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease: plasma concentrations exceed target levels, with drug accumulation in the most severe patients
por: Scott, Janet T., et al.
Publicado: (2020)

Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort
por: Hall, Matthew D, et al.
Publicado: (2021)

1421. IV Brincidofovir (BCV): Pharmacokinetics (PK) and Safety of Multiple Ascending Doses (MAD) in Healthy Subjects
por: Naderer, Odin, et al.
Publicado: (2018)

Brincidofovir Use after Foscarnet Crystal Nephropathy in a Kidney Transplant Recipient with Multiresistant Cytomegalovirus Infection
por: Vial, Romain, et al.
Publicado: (2017)

Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model
por: Hutson, Christina L., et al.
Publicado: (2021)

First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease
por: Dörnemann, Jenny, et al.
Publicado: (2017)

Analysis of Mutations in the Gene Encoding Cytomegalovirus DNA Polymerase in a Phase 2 Clinical Trial of Brincidofovir Prophylaxis
por: Lanier, E. Randall, et al.
Publicado: (2016)

Sensitivity of Human Mastadenovirus, the Causal Agent of Pharyngoconjunctival Fever, Epidemic Keratoconjunctivitis, and Hemorrhagic Cystitis in Immunocompromised Individuals, to Brincidofovir
por: Hanaoka, Nozomu, et al.
Publicado: (2022)

Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects
por: Imran, Mohd., et al.
Publicado: (2023)

Chemoprophylaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations
por: Manoharan, Lakshmi, et al.
Publicado: (2021)

Using a consensus technique for improving the methodology of clinical trials assessing treatments for Cutaneous Leishmaniasis
por: Erber, Astrid, et al.
Publicado: (2015)

Brincidofovir Is Not a Substrate for the Human Organic Anion Transporter 1: A Mechanistic Explanation for the Lack of Nephrotoxicity Observed in Clinical Studies
por: Tippin, Timothy K., et al.
Publicado: (2016)

Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection
por: Faure, Emmanuel, et al.
Publicado: (2016)

Randomised controlled trials for mpox in endemic countries
por: Rojek, Amanda, et al.
Publicado: (2023)

Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection: Erratum
Publicado: (2017)

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
por: Marty, Francisco M., et al.
Publicado: (2018)

Correction for Hutson et al., “Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model”
por: Hutson, Christina L., et al.
Publicado: (2021)

Evaluating clinical characteristics studies produced early in the Covid-19 pandemic: A systematic review
por: Manoharan, Lakshmi, et al.
Publicado: (2021)

Time to reconsider the role of ribavirin in Lassa fever
por: Salam, Alex Paddy, et al.
Publicado: (2021)

Molecular docking suggests repurposing of brincidofovir as a potential drug targeting SARS-CoV-2 ACE2 receptor and main protease
por: Hussien, Mostafa A., et al.
Publicado: (2020)

Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus
por: Parker, Scott, et al.
Publicado: (2014)

Long COVID: tackling a multifaceted condition requires a multidisciplinary approach
por: Norton, Alice, et al.
Publicado: (2021)

The Schistosomiasis Clinical Trials Landscape: A Systematic Review of Antischistosomal Treatment Efficacy Studies and a Case for Sharing Individual Participant-Level Data (IPD)
por: Julé, Amélie M., et al.
Publicado: (2016)

The impact of control strategies and behavioural changes on the elimination of Ebola from Lofa County, Liberia
por: Funk, Sebastian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bkbp5nqnmdng6t87nfnldi8k55